語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Parasitic helminths[electronic resou...
~
Caffrey, Conor R.
Parasitic helminths[electronic resource] :targets, screens, drugs and vaccines /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
616.96061
書名/作者:
Parasitic helminths : targets, screens, drugs and vaccines // edited by Conor R. Caffrey.
其他作者:
Caffrey, Conor R.
出版者:
Weinheim, Germany : : Wiley-VCH,, 2012.
面頁冊數:
1 online resource (xxiii, 516 p. :) : ill. (some col.).
標題:
Helminths.
標題:
Parasites.
標題:
Parasitic diseases - Treatment.
標題:
Parasitic diseases - Diagnosis.
ISBN:
9783527652969 (electronic bk.)
ISBN:
3527652965 (electronic bk.)
書目註:
Includes bibliographical references and index.
內容註:
Part one: targets -- Ligand-gated ion channels as targets for anthelmintic drugs: past, current, and future perspectives -- How relevant is Caenorhabditis elegans as a model for the analysis of parasitic nematode biology? -- Integrating and mining helminth genomes to discover and prioritize novel therapeutic targets -- Recent progress in transcriptomics of key gastrointestinal nematodes of animals: fundamental research toward new intervention strategies -- Harnessing genomic technologies to explore the molecular biology of liver flukes-major implications for fundamental and applied research -- RNA interference: a potential discovery tool for therapeutic targets of parasitic nematodes -- RNA interference as a tool for drug discovery in parasitic flatworms -- Part two: screens -- Mechanism-based screening strategies for anthelmintic discovery -- Identification and profiling of nematicidal compounds in veterinary parasitology -- Quantitative high-content screening-based drug discovery against helmintic diseases -- Use of rodent models in the discovery of novel anthelmintics -- To kill a mocking worm: strategies to improve Caenorhabditis elegans as a model system for use in anthelmintic discovery -- Part three: drugs -- Anthelmintic drugs: tools and shortcuts for the long road from discovery to product -- Antinematodal drugs: modes of action and resistance: and worms will not come to thee (Shakespeare: Cymbeline: iv, ii) -- Drugs and targets to perturb the symbiosis of Wolbachia and filarial nematodes -- Promise of Bacillus thuringiensis crystal proteins as anthelmintics -- Monepantel: from discovery to mode of action -- Discovery, mode of action, and commercialization of derquantel -- Praziquantel: too good to be replaced? -- Drug discovery for trematodiases: challenges and progress -- Part four: vaccines -- Barefoot thru' the valley of darkness: preclinical development of a human hookworm vaccine -- Vaccines linked to chemotherapy: a new approach to control helminth infections -- Antifilarial vaccine development: present and future approaches -- Proteases as vaccines against gastrointestinal nematode parasites of sheep and cattle -- Schistosomiasis vaccines: new approaches to antigen discovery and promising new candidates -- Sm14 Schistosoma mansoni fatty acid-binding protein: molecular basis for an antihelminth vaccine -- Mechanisms of immune modulation by Fasciola hepatica: importance for vaccine development and for novel immunotherapeutics -- Prospects for immunoprophylaxis against Fasciola hepatica (liver fluke) -- Vaccines against cestode parasites.
電子資源:
http://onlinelibrary.wiley.com/book/10.1002/9783527652969
Parasitic helminths[electronic resource] :targets, screens, drugs and vaccines /
Parasitic helminths
targets, screens, drugs and vaccines /[electronic resource] :edited by Conor R. Caffrey. - Weinheim, Germany :Wiley-VCH,2012. - 1 online resource (xxiii, 516 p. :)ill. (some col.). - Drug discovery in infectious diseases ;v. 3. - Drug discovery in infectious diseases ;v. 4..
Includes bibliographical references and index.
Part one: targets -- Ligand-gated ion channels as targets for anthelmintic drugs: past, current, and future perspectives -- How relevant is Caenorhabditis elegans as a model for the analysis of parasitic nematode biology? -- Integrating and mining helminth genomes to discover and prioritize novel therapeutic targets -- Recent progress in transcriptomics of key gastrointestinal nematodes of animals: fundamental research toward new intervention strategies -- Harnessing genomic technologies to explore the molecular biology of liver flukes-major implications for fundamental and applied research -- RNA interference: a potential discovery tool for therapeutic targets of parasitic nematodes -- RNA interference as a tool for drug discovery in parasitic flatworms -- Part two: screens -- Mechanism-based screening strategies for anthelmintic discovery -- Identification and profiling of nematicidal compounds in veterinary parasitology -- Quantitative high-content screening-based drug discovery against helmintic diseases -- Use of rodent models in the discovery of novel anthelmintics -- To kill a mocking worm: strategies to improve Caenorhabditis elegans as a model system for use in anthelmintic discovery -- Part three: drugs -- Anthelmintic drugs: tools and shortcuts for the long road from discovery to product -- Antinematodal drugs: modes of action and resistance: and worms will not come to thee (Shakespeare: Cymbeline: iv, ii) -- Drugs and targets to perturb the symbiosis of Wolbachia and filarial nematodes -- Promise of Bacillus thuringiensis crystal proteins as anthelmintics -- Monepantel: from discovery to mode of action -- Discovery, mode of action, and commercialization of derquantel -- Praziquantel: too good to be replaced? -- Drug discovery for trematodiases: challenges and progress -- Part four: vaccines -- Barefoot thru' the valley of darkness: preclinical development of a human hookworm vaccine -- Vaccines linked to chemotherapy: a new approach to control helminth infections -- Antifilarial vaccine development: present and future approaches -- Proteases as vaccines against gastrointestinal nematode parasites of sheep and cattle -- Schistosomiasis vaccines: new approaches to antigen discovery and promising new candidates -- Sm14 Schistosoma mansoni fatty acid-binding protein: molecular basis for an antihelminth vaccine -- Mechanisms of immune modulation by Fasciola hepatica: importance for vaccine development and for novel immunotherapeutics -- Prospects for immunoprophylaxis against Fasciola hepatica (liver fluke) -- Vaccines against cestode parasites.
ISBN: 9783527652969 (electronic bk.)Subjects--Topical Terms:
494066
Helminths.
LC Class. No.: RC119.7 / .P37 2012eb
Dewey Class. No.: 616.96061
Parasitic helminths[electronic resource] :targets, screens, drugs and vaccines /
LDR
:03665cam a2200289Ma 4500
001
437858
003
OCoLC
005
20151014041123.0
006
m o d
007
cr |||||||||||
008
160125s2012 gw a ob 001 0 eng d
020
$a
9783527652969 (electronic bk.)
020
$a
3527652965 (electronic bk.)
020
$z
9783527330591
020
$z
9783527652938 (e-book)
035
$a
(OCoLC)802056669
035
$a
ocn802056669
040
$a
E7B
$c
E7B
$d
OCLCO
$d
CDX
$d
DG1
$d
YDXCP
$d
OCLCQ
$d
MMU
$d
OCLCF
$d
COO
050
4
$a
RC119.7
$b
.P37 2012eb
082
0 4
$a
616.96061
$2
23
245
0 0
$a
Parasitic helminths
$h
[electronic resource] :
$b
targets, screens, drugs and vaccines /
$c
edited by Conor R. Caffrey.
260
$a
Weinheim, Germany :
$b
Wiley-VCH,
$c
2012.
300
$a
1 online resource (xxiii, 516 p. :)
$b
ill. (some col.).
490
1
$a
Drug discovery in infectious diseases ;
$v
v. 3
504
$a
Includes bibliographical references and index.
505
0
$a
Part one: targets -- Ligand-gated ion channels as targets for anthelmintic drugs: past, current, and future perspectives -- How relevant is Caenorhabditis elegans as a model for the analysis of parasitic nematode biology? -- Integrating and mining helminth genomes to discover and prioritize novel therapeutic targets -- Recent progress in transcriptomics of key gastrointestinal nematodes of animals: fundamental research toward new intervention strategies -- Harnessing genomic technologies to explore the molecular biology of liver flukes-major implications for fundamental and applied research -- RNA interference: a potential discovery tool for therapeutic targets of parasitic nematodes -- RNA interference as a tool for drug discovery in parasitic flatworms -- Part two: screens -- Mechanism-based screening strategies for anthelmintic discovery -- Identification and profiling of nematicidal compounds in veterinary parasitology -- Quantitative high-content screening-based drug discovery against helmintic diseases -- Use of rodent models in the discovery of novel anthelmintics -- To kill a mocking worm: strategies to improve Caenorhabditis elegans as a model system for use in anthelmintic discovery -- Part three: drugs -- Anthelmintic drugs: tools and shortcuts for the long road from discovery to product -- Antinematodal drugs: modes of action and resistance: and worms will not come to thee (Shakespeare: Cymbeline: iv, ii) -- Drugs and targets to perturb the symbiosis of Wolbachia and filarial nematodes -- Promise of Bacillus thuringiensis crystal proteins as anthelmintics -- Monepantel: from discovery to mode of action -- Discovery, mode of action, and commercialization of derquantel -- Praziquantel: too good to be replaced? -- Drug discovery for trematodiases: challenges and progress -- Part four: vaccines -- Barefoot thru' the valley of darkness: preclinical development of a human hookworm vaccine -- Vaccines linked to chemotherapy: a new approach to control helminth infections -- Antifilarial vaccine development: present and future approaches -- Proteases as vaccines against gastrointestinal nematode parasites of sheep and cattle -- Schistosomiasis vaccines: new approaches to antigen discovery and promising new candidates -- Sm14 Schistosoma mansoni fatty acid-binding protein: molecular basis for an antihelminth vaccine -- Mechanisms of immune modulation by Fasciola hepatica: importance for vaccine development and for novel immunotherapeutics -- Prospects for immunoprophylaxis against Fasciola hepatica (liver fluke) -- Vaccines against cestode parasites.
588
$a
Description based on print version record.
650
0
$a
Helminths.
$3
494066
650
0
$a
Parasites.
$3
624844
650
0
$a
Parasitic diseases
$x
Treatment.
$3
622726
650
0
$a
Parasitic diseases
$x
Diagnosis.
$3
624845
700
1
$a
Caffrey, Conor R.
$3
624843
830
0
$a
Drug discovery in infectious diseases ;
$v
v. 4.
$3
588099
856
4 0
$u
http://onlinelibrary.wiley.com/book/10.1002/9783527652969
筆 0 讀者評論
多媒體
多媒體檔案
http://onlinelibrary.wiley.com/book/10.1002/9783527652969
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入